Development of AZD5363, an inhibitor of AKT with activity in tumours containing mutations in the P13K-AKT pathway
Abstract not yet added
Date: 2 November 2015, 11:00 (Monday, 4th week, Michaelmas 2015)
Venue: Old Road Campus Research Building, Headington OX3 7DQ
Venue Details: 71A, B and C
Speaker: Dr Barry Davis ( AstraZeneca)
Organising department: Department of Oncology
Organiser: Linda Nemerofksy-Birks (University of Oxford)
Host: Anderson Ryan (University of Oxford )
Part of: Department of Oncology
Booking required?: Not required
Audience: Members of the University only
Editor: Amanda Chapman